Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tradition Meets Innovation -­ Greiner Bio-One Celebrates 50 Successful Years

Published: Friday, December 13, 2013
Last Updated: Thursday, December 12, 2013
Bookmark and Share
Company now has over 1,700 employees spread across seven production facilities.

This year marks the 50th anniversary of Greiner Bio-One GmbH. Over the past five decades, the business founded in Nürtingen, Germany, as Greiner Labortechnik has become an international high-tech company, but it has never lost sight of its modest SMB roots.

Combining tradition with innovation has created a globally successful technology partner for the diagnostic, pharmaceutical and biotechnology industries.

Greiner Labortechnik started out in 1963 in Nürtingen, producing the first plastic Petri dishes. A further production facility that opened in Austria in 1974 also initially manufactured Petri dishes.

In the 1980s, Greiner unveiled VACUETTE ­ the first evacuated blood collection system with a plastic safety cap ­ which can maintain a vacuum for at least 18 months.

This extremely important innovation was key in shaping the company’s further development. Another major breakthrough came in 1997 with the world’s first 1536 well microplate.

In 1988, an ultramodern 15,000 square metre injection moulding production facility opened in Frickenhausen, near Nürtingen. The company also invested in a new production site in the United States and, in 2001, Greiner Labortechnik became Greiner Bio-One International AG.

With a global turnover of 364 million euros, Greiner now has over 1,700 employees spread across seven production facilities and 24 subsidiaries in countries such as France, the Netherlands, Belgium, the United Kingdom, Japan, Hungary, the United States, Switzerland, Brazil, Thailand, China and India.

Based in the Austrian town of Kremsmünster, the Preanalytics division supplies hospitals, clinical laboratories, blood donation centres and the diagnostics industry with complete solutions for venous and capillary blood collection.

Innovations include safety products to protect against needlestick injuries and the VACUETTE PREMIUM tubes with a special screw cap that protect health service professionals against infections.

The division’s latest development is the VACUETTE TUBE TOUCH safety holder. When inserting the tube into the holder, a mechanism activates a safety cap to ensure risk-free blood collection.

The Diagnostics division focuses on DNA chip technology. Biochips provide conclusive proof of the specific genetic fingerprints of many different parameters in a single analysis. The CarnoCheck DNA chip, for example, detects traces of various animal species in food products.

A further significant Greiner Bio-One innovation is the PapilloCheck HPV test, which reliably identifies and flags up 24 strains of the human papillomavirus (HPV). This has taken Greiner Bio-One a big step forward in the early detection of a virus that is the main cause of cervical cancer.

Headed by managing director Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen control all research and development activities in the Cell Culture, High-Throughput Screening and OEM product sectors for markets throughout the world.

Schmid, who started his career as a trainee at the company, sees the anniversary as more than simply an excuse for nostalgia. “I share my staff’s great pride when I see the trust placed in Greiner Bio-One products by scientists and doctors working in areas such as cancer research, virus diagnostics and vaccine production the world over. We are committed to always delivering optimum solutions with our innovations,” he says.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Yeast Cells Use Signaling Pathway to Modify Their Genomes
Researchers at the Babraham Institute and Cambridge Systems Biology Centre, University of Cambridge have shown that yeast can modify their genomes to take advantage of an excess of calories in the environment and attain optimal growth.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
New Measurements Reveal Differences Between Stem Cells for Treating Retinal Degeneration
By growing two types of stem cells in a “3-D culture” and measuring their ability to produce retinal cells, a team lead by St. Jude Children’s Research Hospital researchers has found one cell type to be better at producing retinal cells.
Researchers Identify Critical Genes Responsible for Brain Tumor Growth
After generating new brain tumor models scientists have identified the role of a family of genes underlying tumor growth in a wide spectrum of high grade brain tumors.
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
A New Path Towards a Universal Flu Vaccine
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
How Anthrax Spores Grow in Cultured Human Tissues
New findings to help predict risk and outcomes of anthrax attacks.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!